Open AccessIncidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy
Author(s) -
Nick Thoreson,
Jason A. Park,
Chris Grasso,
Jennifer Potter,
Dana King,
Linda G. Marc,
Changyu Shen,
J. Klint Peebles,
Erica D. Dommasch
Publication year - 2021
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2020.5347
Subject(s) - medicine , acne , incidence (geometry) , interquartile range , population , univariate analysis , pediatrics , multivariate analysis , dermatology , environmental health , physics , optics
Acne is a common condition among transgender patients receiving masculinizing hormone therapy (MHT), but the incident risk and predictors of developing acne in this population have not yet been studied on a large scale.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom